1	Tpl-2	tpl-2	_	_	_	_	_	_	_
2	induces	induce	_	_	_	_	_	_	_
3	IL-2	il-2	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	T-cell	t-cell	_	_	_	_	_	_	_
7	lines	line	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	triggering	trigger	_	_	_	_	_	_	_
10	multiple	multiple	_	_	_	_	_	_	_
11	signaling	signaling	_	_	_	_	_	_	_
12	pathways	pathway	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	activate	activate	_	_	_	_	_	_	_
15	NFAT	NFAT	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	Tpl-2	Tpl-2	_	_	_	_	_	_	_
3	kinase	kinase	_	_	_	_	_	_	_
4	activates	activate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	activated	activate	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	NFAT	NFAT	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	induces	induce	_	_	_	_	_	_	_
17	IL-2	il-2	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	T-cell	t-cell	_	_	_	_	_	_	_
21	lines	line	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	IL-2	il-2	_	_	_	_	_	_	_
10	promoter	promoter	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	Tpl-2	tpl-2	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	inhibited	inhibit	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	mutant	mutant	_	_	_	_	_	_	_
17	signaling	signal	_	_	_	_	_	_	_
18	molecules	molecule	_	_	_	_	_	_	_
19	that	that	_	_	_	_	_	_	_
20	inhibit	inhibit	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	mitogen-activated	mitogen-activated	_	_	_	_	_	_	_
23	protein	protein	_	_	_	_	_	_	_
24	kinase	kinase	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	MAPK	MAPK	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	or	or	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	calcineurin/NFAT	calcineurin/nfat	_	_	_	_	_	_	_
31	pathways	pathway	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	is	be	_	_	_	_	_	_	_
34	promoted	promote	_	_	_	_	_	_	_
35	by	by	_	_	_	_	_	_	_
36	combinations	combination	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	signaling	signal	_	_	_	_	_	_	_
39	molecules	molecule	_	_	_	_	_	_	_
40	that	that	_	_	_	_	_	_	_
41	activate	activate	_	_	_	_	_	_	_
42	these	these	_	_	_	_	_	_	_
43	pathways	pathway	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	therefore	therefore	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	conclude	conclude	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	signals	signal	_	_	_	_	_	_	_
8	generated	generate	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	convergence	convergence	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	MAPK	MAPK	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	calcineurin/NFAT	calcineurin/nfat	_	_	_	_	_	_	_
18	pathway	pathway	_	_	_	_	_	_	_
19	are	be	_	_	_	_	_	_	_
20	necessary	necessary	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	sufficient	sufficient	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	activation	activation	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	promoter	promoter	_	_	_	_	_	_	_
30	by	by	_	_	_	_	_	_	_
31	Tpl-2	tpl-2	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	both	both	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	promoter	promoter	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	NFAT-driven	nfat-driven	_	_	_	_	_	_	_
11	minimal	minimal	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	were	be	_	_	_	_	_	_	_
14	shown	show	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	depend	depend	_	_	_	_	_	_	_
17	on	on	_	_	_	_	_	_	_
18	signals	signal	_	_	_	_	_	_	_
19	transduced	transduce	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	Raf1	Raf1	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	it	it	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	only	only	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	promoter	promoter	_	_	_	_	_	_	_
9	whose	whose	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	Tpl-2	tpl-2	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	fully	fully	_	_	_	_	_	_	_
15	blocked	block	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	dominant	dominant	_	_	_	_	_	_	_
19	negative	negative	_	_	_	_	_	_	_
20	mutant	mutant	_	_	_	_	_	_	_
21	MEK1S218/222A	MEK1S218/222A	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	MEK1/MEK2	mek1/mek2	_	_	_	_	_	_	_
25	inhibitor	inhibitor	_	_	_	_	_	_	_
26	PD098059	pd098059	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NFAT	NFAT	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	MAPK-dependent	mapk-dependent	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	findings	finding	_	_	_	_	_	_	_
10	suggested	suggest	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	MAPK	MAPK	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	Tpl-2	tpl-2	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	either	either	_	_	_	_	_	_	_
20	independent	independent	_	_	_	_	_	_	_
21	or	or	_	_	_	_	_	_	_
22	only	only	_	_	_	_	_	_	_
23	partially	partially	_	_	_	_	_	_	_
24	dependent	dependent	_	_	_	_	_	_	_
25	on	on	_	_	_	_	_	_	_
26	MEK1	MEK1	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	MEK2	MEK2	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	they	they	_	_	_	_	_	_	_
5	suggested	suggest	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	under	under	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	control	control	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	only	only	_	_	_	_	_	_	_
20	NFAT	nfat	_	_	_	_	_	_	_
21	but	but	_	_	_	_	_	_	_
22	also	also	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	second	second	_	_	_	_	_	_	_
25	factor	factor	_	_	_	_	_	_	_
26	whose	whose	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	is	be	_	_	_	_	_	_	_
29	MEK-dependent	mek-dependent	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Experiments	experiment	_	_	_	_	_	_	_
2	in	in	_	_	_	_	_	_	_
3	COS-1	cos-1	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	EL-4	el-4	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	confirmed	confirm	_	_	_	_	_	_	_
8	both	both	_	_	_	_	_	_	_
9	hypotheses	hypothesis	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	revealed	reveal	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	second	second	_	_	_	_	_	_	_
15	factor	factor	_	_	_	_	_	_	_
16	activated	activate	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	Tpl-2	tpl-2	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	While	while	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	promoter	promoter	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	NFAT-driven	nfat-driven	_	_	_	_	_	_	_
11	minimal	minimal	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	Tpl-2	tpl-2	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	fully	fully	_	_	_	_	_	_	_
17	blocked	block	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	dominant	dominant	_	_	_	_	_	_	_
21	negative	negative	_	_	_	_	_	_	_
22	mutant	mutant	_	_	_	_	_	_	_
23	NFAT	NFAT	_	_	_	_	_	_	_
24	delta418	delta418	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	it	it	_	_	_	_	_	_	_
27	was	be	_	_	_	_	_	_	_
28	only	only	_	_	_	_	_	_	_
29	partially	partially	_	_	_	_	_	_	_
30	blocked	block	_	_	_	_	_	_	_
31	by	by	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	calcineurin	calcineurin	_	_	_	_	_	_	_
34	inhibitor	inhibitor	_	_	_	_	_	_	_
35	cyclosporin	cyclosporin	_	_	_	_	_	_	_
36	A	a	_	_	_	_	_	_	_
37	suggesting	suggest	_	_	_	_	_	_	_
38	that	that	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	Tpl-2-mediated	tpl-2-mediated	_	_	_	_	_	_	_
41	NFAT	NFAT	_	_	_	_	_	_	_
42	activation	activation	_	_	_	_	_	_	_
43	is	be	_	_	_	_	_	_	_
44	under	under	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	control	control	_	_	_	_	_	_	_
47	of	of	_	_	_	_	_	_	_
48	a	a	_	_	_	_	_	_	_
49	combination	combination	_	_	_	_	_	_	_
50	of	of	_	_	_	_	_	_	_
51	calcineurin-dependent	calcineurin-dependent	_	_	_	_	_	_	_
52	and	and	_	_	_	_	_	_	_
53	independent	independent	_	_	_	_	_	_	_
54	pathways	pathway	_	_	_	_	_	_	_
55	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	pathways	pathway	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	fully	fully	_	_	_	_	_	_	_
5	blocked	block	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	Bcl-2	bcl-2	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	Bcl-X(L)	Bcl-X(L)	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

